This document summarizes regulations regarding the import of drugs and cosmetics into India. It defines key terms like drugs, cosmetics, misbranded drugs, adulterated drugs, spurious drugs, misbranded cosmetics, and spurious cosmetics. It outlines rules for importing drugs under a license, including for Schedule C, C1, and X drugs. It also discusses importing drugs for personal use, importing new drugs, and importing drugs by government hospitals. Exceptions to import rules are provided. Finally, penalties for contravening import provisions are stated.
LINK FOR VIDEO LECTURES
https://youtu.be/-4nzP2vOGdg
DRUG TECHNICAL ADVISORY BOARD IS IN THE PHARMACY SYLLABUS AND THE QUESTIONS ARE ASKED IN THE PHARMACY EXAMS .
SUCH AS GPAT NIPER AND SEMSESTER EXAM/
This document provides an overview of the administration of the Drugs and Cosmetics Act and Rules in India. It discusses the roles of various analytical, executive, and advisory bodies involved in drug regulation. It also outlines the qualifications, duties, and powers of key regulatory positions like Government Analysts, Drugs Inspectors, and the procedures they follow to inspect facilities, collect samples, test drugs, and take action if drugs are found to be substandard.
The document summarizes the constitution and functions of key organizations under the Drugs and Cosmetics Act of 1940 and Rules of 1945 in India. The Drugs Technical Advisory Board (DTAB) advises the central and state governments and consists of 18 ex-officio and nominated members. The Drugs Consultative Committee (DCC) advises on securing uniformity and consists of central and state government representatives. The Central Drugs Laboratory (CDL) in Kolkata analyzes drug and cosmetic samples sent by courts and customs and maintains reference standards.
Medicinal and toilet preparations act and rules,1955Ganesh Shevalkar
It is an Act with provision for levy and collection of excise duties on medicinal and toilet preparations containing alcohol, opium, Indian hemp (cannabis) or other narcotic drugs.
The document summarizes the key aspects of the Medicinal and Toilet Preparations Act and Rules, 1955 in India. The objectives of the act are to provide for excise duties on medicinal and toilet preparations containing alcohol, narcotics or drugs and to control their manufacture and misuse. The act defines relevant terms and outlines the licensing process and requirements for the manufacture of such preparations both within bonded premises and outside. It also describes the duties and powers of excise officers, search and seizure procedures, offenses and penalties. The schedule lists the categories of dutiable goods and applicable rates of duty.
This presentation is related to the drug price control order in India. It will give an idea to the readers how the prices have been fixed for the formulations. How the price has been calculated for scheduled formulations.
The document summarizes key aspects of the Drug and Cosmetic Act and Rules in India, including:
- The Acts and Rules regulate the import, manufacture, distribution and sale of drugs and cosmetics in India.
- Important definitions are provided for terms like "drug", "cosmetic", "manufacture" and others.
- Drugs and cosmetics can be deemed "misbranded", "adulterated" or "spurious" if they do not meet certain standards.
- The Rules contain 18 parts and 26 schedules providing detailed requirements and guidelines for drugs and cosmetics.
- Key agencies like the Drugs Technical Advisory Board help administer the Acts and
4 medicinal and toilet preparation act 1955Charudatta Jog
This document outlines the Medicinal & Toilet Preparation Act of 1955, which was passed to standardize excise duties across states in India. The key objectives of the act were to levy and collect duties on alcohol used in medicinal and toilet preparations and curb irregularities. The act established procedures for licensing the manufacture of preparations containing alcohol or narcotics. It also differentiated between manufacturing processes that took place within bonded laboratories versus outside of them, and outlined exemptions, duties, and responsibilities of excise officers in enforcing the act.
LINK FOR VIDEO LECTURES
https://youtu.be/-4nzP2vOGdg
DRUG TECHNICAL ADVISORY BOARD IS IN THE PHARMACY SYLLABUS AND THE QUESTIONS ARE ASKED IN THE PHARMACY EXAMS .
SUCH AS GPAT NIPER AND SEMSESTER EXAM/
This document provides an overview of the administration of the Drugs and Cosmetics Act and Rules in India. It discusses the roles of various analytical, executive, and advisory bodies involved in drug regulation. It also outlines the qualifications, duties, and powers of key regulatory positions like Government Analysts, Drugs Inspectors, and the procedures they follow to inspect facilities, collect samples, test drugs, and take action if drugs are found to be substandard.
The document summarizes the constitution and functions of key organizations under the Drugs and Cosmetics Act of 1940 and Rules of 1945 in India. The Drugs Technical Advisory Board (DTAB) advises the central and state governments and consists of 18 ex-officio and nominated members. The Drugs Consultative Committee (DCC) advises on securing uniformity and consists of central and state government representatives. The Central Drugs Laboratory (CDL) in Kolkata analyzes drug and cosmetic samples sent by courts and customs and maintains reference standards.
Medicinal and toilet preparations act and rules,1955Ganesh Shevalkar
It is an Act with provision for levy and collection of excise duties on medicinal and toilet preparations containing alcohol, opium, Indian hemp (cannabis) or other narcotic drugs.
The document summarizes the key aspects of the Medicinal and Toilet Preparations Act and Rules, 1955 in India. The objectives of the act are to provide for excise duties on medicinal and toilet preparations containing alcohol, narcotics or drugs and to control their manufacture and misuse. The act defines relevant terms and outlines the licensing process and requirements for the manufacture of such preparations both within bonded premises and outside. It also describes the duties and powers of excise officers, search and seizure procedures, offenses and penalties. The schedule lists the categories of dutiable goods and applicable rates of duty.
This presentation is related to the drug price control order in India. It will give an idea to the readers how the prices have been fixed for the formulations. How the price has been calculated for scheduled formulations.
The document summarizes key aspects of the Drug and Cosmetic Act and Rules in India, including:
- The Acts and Rules regulate the import, manufacture, distribution and sale of drugs and cosmetics in India.
- Important definitions are provided for terms like "drug", "cosmetic", "manufacture" and others.
- Drugs and cosmetics can be deemed "misbranded", "adulterated" or "spurious" if they do not meet certain standards.
- The Rules contain 18 parts and 26 schedules providing detailed requirements and guidelines for drugs and cosmetics.
- Key agencies like the Drugs Technical Advisory Board help administer the Acts and
4 medicinal and toilet preparation act 1955Charudatta Jog
This document outlines the Medicinal & Toilet Preparation Act of 1955, which was passed to standardize excise duties across states in India. The key objectives of the act were to levy and collect duties on alcohol used in medicinal and toilet preparations and curb irregularities. The act established procedures for licensing the manufacture of preparations containing alcohol or narcotics. It also differentiated between manufacturing processes that took place within bonded laboratories versus outside of them, and outlined exemptions, duties, and responsibilities of excise officers in enforcing the act.
These presentation describes the rules and regulations for the manufacture of drugs and grant of license. Loan License and Repacking License is also described. These presentation is the part of series Drugs & Cosmetics Act.
The application for Registration and import can be made to the Licensing Authority under the Act i.e. to the Drugs Controller General at CDSCO. Drug and Cosmetic Act 1945: It Contains provisions for classification of drugs under given schedules. Guidelines for the storage,sale,display and prescription of each schedule.
State pharmacy council and joint state pharmacy council:
Under the Pharmacy Act each Sate Govt. is required to constitute a state pharmacy council for the maintenance of register of Pharmacists of the State and to monitor their professional activities.
Two or more states can also enter into an agreement to form a Joint State Pharmacy Council.
in that presentation information regarding how to start pharmaceutical acts in all over India & also provides history of pharmaceutical legislation in India
Schedule M outlines Good Manufacturing Practices (GMP) that must be followed by pharmaceutical manufacturing units in India. It contains requirements for factory premises, plants, equipment, and quality assurance to ensure products are consistently manufactured and controlled to quality standards. Schedule M has two parts - Part 1 covers GMP for premises and materials, and Part 2 covers specific plant and material requirements. It provides detailed guidelines for facilities, equipment, sanitation, personnel, documentation, manufacturing, quality control, distribution, and more to help ensure therapeutic goods produced meet the required quality standards.
A drug inspector is responsible for monitoring and ensuring the safety, quality, and effectiveness of drugs from production to sale. To become a drug inspector, candidates must have a pharmacy or pharmaceutical science degree, 18 months of relevant work experience, and pass a written exam consisting of two papers testing knowledge of pharmacy and general knowledge. Drug inspectors have the power to inspect any premises or records involved in drug manufacturing, sample and test drugs, inspect licenses, and cancel licenses of businesses found to have quality or standards issues. The role requires skills in discipline, patience, self-confidence, and keeping updated in the pharmaceutical field.
This document outlines general and special labeling requirements for drugs and cosmetics under the Drugs & Cosmetics Act of 1940 and its Rules of 1945 in India. It provides details on what information must be included on labels, such as the drug name, ingredients, manufacturer information, batch details, and expiry date. It also specifies additional labeling for certain drug schedules, like Schedule H which requires a prescription, as well as for external preparations, ophthalmic products, and veterinary medicines. Sample labels are given for various drug schedules and uses. The document also lists permitted colors that can be used in drugs.
The document summarizes the Pharmacy Act of 1948 in India. It establishes the Central Council of Pharmacy to regulate the profession of pharmacy by prescribing minimum education standards. The Council maintains a central register of pharmacists. The Act also creates State Pharmacy Councils to oversee pharmacists at the state level and issue registrations. Its objectives are to regulate and raise the standards of pharmacy education and practice across India.
A presentation aimed at providing information with regards to the Pharmacy Act, 1948.
-INTRODUCTION
-HISTORY OF THE ACT
-PHARMACY COUNCIL OF INDIA
-STATE PHARMACY COUNCIL
-SPECIAL PROVISIONS OF THE ACT
-OFFENCES AND PENALTIES
-CONCLUSION
-REFERENCES
This act gives an idea about the constitution and functions of PCI. Brief about Education Regulation in India. Registration procedure for the pharmacist in India.
At the end of the 19th century and early 20 century use of Allopathy system increases
Drugs of natural origin: Veg, mineral oil and animals
At that time, profit became main motive than service
Overdose of quinine.A Central law to control drugs and pharmacy profession.
Medicinal and toilatory preparation act 1955 Suvarta Maru
This document discusses the Medicinal and Toilet Preparation Act of 1955 and related rules from 1976 regarding the production and regulation of alcoholic preparations in India. It outlines key definitions including bonded and non-bonded manufactories. There are two modes of manufacturing preparations containing alcohol - in bond, using untaxed alcohol under excise supervision, or outside bond using taxed alcohol. The licensing process and ideal facility requirements are described. Responsibilities of excise officers who oversee the facilities and powers granted to them are also summarized.
This document summarizes the key points of the Medicinal & Toilet preparations act of 1955 and rules thereunder from 1976 regarding the production of medicines and toiletries containing alcohol or other substances. It defines key terms, outlines the licensing process for bonded and non-bonded laboratories, and describes the requirements for facilities. Offenses and penalties are also specified for licensees, excise officers, and the public. The overall objective is to regulate the use of substances like alcohol in medical and personal care products through a licensing and inspection process, as well as by defining illegal activities and associated penalties.
The document discusses the evaluation and testing of tablets. It describes non-official tests like general appearance, organoleptic properties, size and shape, hardness, and friability. It also describes official tests like weight variation, content uniformity, dissolution, and disintegration. It discusses different types of tablets like compressed and molded tablets. It provides details on evaluating the appearance, hardness, friability and other properties of tablets and describes tests like weight variation, content uniformity, and dissolution used to ensure tablets meet specifications.
A detailed study on tablets, its classification, excipients, tablet granulation, methods of granulation, compression machines, equipment tooling and the problems that occur during the tablet manufacturing process. This presentation is based on the PCI syllabus for bpharm students of fifth semester.
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Sagar Savale
An Act to control the advertisement of drugs in certain cases, to prohibit the advertisement for certain purposes of remedies alleged to possess magic qualities and to provide for matters connected therewith. This act is not unconstitutional, because it does not interferes with private business and also it does not impose unreasonable restrictions.
This document provides information about the nutraceutical properties of various herbs and foods. It discusses the health benefits of nutraceuticals in treating diseases like diabetes, cardiovascular diseases, cancer, and gastrointestinal issues. Key points covered include the classification of nutraceuticals, probiotics and prebiotics, polyunsaturated fatty acids, vitamins, and the traditional and global market of nutraceuticals. Specific herbs discussed include alfalfa, chicory, ginger, fenugreek, garlic, and honey.
Bio pharmaceutical classification System [BCS]Sagar Savale
The Biopharmaceutical Classification System was first developed by in 1995, by Amidon et al & his colleagues.
Definition:
“The Biopharmaceutical Classification System is a scientific framework for classifying a drug substance based on its aqueous solubility & intestinal permeability & dissolution rate”.
To saved time fast screening is required so drug substances are classified on basis of solubility and permeability. This classification is called Biopharmaceutical Classification System
Liquid oral topic in Industrial Pharmacy contains many topics like solution, elixirs, syrups, emulsion, and suspension. This topic includes general introduction, types, formulation, components, uses, and Quality control tests. These are also beneficial in other subjects like Pharmaceutics.
This document provides an overview of the Drugs and Cosmetics Act of 1940 and its rules of 1945 in India. It discusses the history and objectives of the act, key definitions, schedules, provisions around importing and manufacturing drugs, licensing requirements, and offenses and penalties. The act was implemented to regulate the drug industry and ensure safety, quality and standards through licensing and inspection. It covers allopathic, ayurvedic, siddha and unani medicines.
Introduction & Objectives
Schedules of the Act.
Schedules of the Rule
Definitions
Administrative bodies
Import & Registration.
Manufacture of drugs
Sale of drugs
Labeling & packaging of drugs
Conditions for grant of licenses
Detailed study of schedules g, h, M, N, P, T, U,V, X & Y
These presentation describes the rules and regulations for the manufacture of drugs and grant of license. Loan License and Repacking License is also described. These presentation is the part of series Drugs & Cosmetics Act.
The application for Registration and import can be made to the Licensing Authority under the Act i.e. to the Drugs Controller General at CDSCO. Drug and Cosmetic Act 1945: It Contains provisions for classification of drugs under given schedules. Guidelines for the storage,sale,display and prescription of each schedule.
State pharmacy council and joint state pharmacy council:
Under the Pharmacy Act each Sate Govt. is required to constitute a state pharmacy council for the maintenance of register of Pharmacists of the State and to monitor their professional activities.
Two or more states can also enter into an agreement to form a Joint State Pharmacy Council.
in that presentation information regarding how to start pharmaceutical acts in all over India & also provides history of pharmaceutical legislation in India
Schedule M outlines Good Manufacturing Practices (GMP) that must be followed by pharmaceutical manufacturing units in India. It contains requirements for factory premises, plants, equipment, and quality assurance to ensure products are consistently manufactured and controlled to quality standards. Schedule M has two parts - Part 1 covers GMP for premises and materials, and Part 2 covers specific plant and material requirements. It provides detailed guidelines for facilities, equipment, sanitation, personnel, documentation, manufacturing, quality control, distribution, and more to help ensure therapeutic goods produced meet the required quality standards.
A drug inspector is responsible for monitoring and ensuring the safety, quality, and effectiveness of drugs from production to sale. To become a drug inspector, candidates must have a pharmacy or pharmaceutical science degree, 18 months of relevant work experience, and pass a written exam consisting of two papers testing knowledge of pharmacy and general knowledge. Drug inspectors have the power to inspect any premises or records involved in drug manufacturing, sample and test drugs, inspect licenses, and cancel licenses of businesses found to have quality or standards issues. The role requires skills in discipline, patience, self-confidence, and keeping updated in the pharmaceutical field.
This document outlines general and special labeling requirements for drugs and cosmetics under the Drugs & Cosmetics Act of 1940 and its Rules of 1945 in India. It provides details on what information must be included on labels, such as the drug name, ingredients, manufacturer information, batch details, and expiry date. It also specifies additional labeling for certain drug schedules, like Schedule H which requires a prescription, as well as for external preparations, ophthalmic products, and veterinary medicines. Sample labels are given for various drug schedules and uses. The document also lists permitted colors that can be used in drugs.
The document summarizes the Pharmacy Act of 1948 in India. It establishes the Central Council of Pharmacy to regulate the profession of pharmacy by prescribing minimum education standards. The Council maintains a central register of pharmacists. The Act also creates State Pharmacy Councils to oversee pharmacists at the state level and issue registrations. Its objectives are to regulate and raise the standards of pharmacy education and practice across India.
A presentation aimed at providing information with regards to the Pharmacy Act, 1948.
-INTRODUCTION
-HISTORY OF THE ACT
-PHARMACY COUNCIL OF INDIA
-STATE PHARMACY COUNCIL
-SPECIAL PROVISIONS OF THE ACT
-OFFENCES AND PENALTIES
-CONCLUSION
-REFERENCES
This act gives an idea about the constitution and functions of PCI. Brief about Education Regulation in India. Registration procedure for the pharmacist in India.
At the end of the 19th century and early 20 century use of Allopathy system increases
Drugs of natural origin: Veg, mineral oil and animals
At that time, profit became main motive than service
Overdose of quinine.A Central law to control drugs and pharmacy profession.
Medicinal and toilatory preparation act 1955 Suvarta Maru
This document discusses the Medicinal and Toilet Preparation Act of 1955 and related rules from 1976 regarding the production and regulation of alcoholic preparations in India. It outlines key definitions including bonded and non-bonded manufactories. There are two modes of manufacturing preparations containing alcohol - in bond, using untaxed alcohol under excise supervision, or outside bond using taxed alcohol. The licensing process and ideal facility requirements are described. Responsibilities of excise officers who oversee the facilities and powers granted to them are also summarized.
This document summarizes the key points of the Medicinal & Toilet preparations act of 1955 and rules thereunder from 1976 regarding the production of medicines and toiletries containing alcohol or other substances. It defines key terms, outlines the licensing process for bonded and non-bonded laboratories, and describes the requirements for facilities. Offenses and penalties are also specified for licensees, excise officers, and the public. The overall objective is to regulate the use of substances like alcohol in medical and personal care products through a licensing and inspection process, as well as by defining illegal activities and associated penalties.
The document discusses the evaluation and testing of tablets. It describes non-official tests like general appearance, organoleptic properties, size and shape, hardness, and friability. It also describes official tests like weight variation, content uniformity, dissolution, and disintegration. It discusses different types of tablets like compressed and molded tablets. It provides details on evaluating the appearance, hardness, friability and other properties of tablets and describes tests like weight variation, content uniformity, and dissolution used to ensure tablets meet specifications.
A detailed study on tablets, its classification, excipients, tablet granulation, methods of granulation, compression machines, equipment tooling and the problems that occur during the tablet manufacturing process. This presentation is based on the PCI syllabus for bpharm students of fifth semester.
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Sagar Savale
An Act to control the advertisement of drugs in certain cases, to prohibit the advertisement for certain purposes of remedies alleged to possess magic qualities and to provide for matters connected therewith. This act is not unconstitutional, because it does not interferes with private business and also it does not impose unreasonable restrictions.
This document provides information about the nutraceutical properties of various herbs and foods. It discusses the health benefits of nutraceuticals in treating diseases like diabetes, cardiovascular diseases, cancer, and gastrointestinal issues. Key points covered include the classification of nutraceuticals, probiotics and prebiotics, polyunsaturated fatty acids, vitamins, and the traditional and global market of nutraceuticals. Specific herbs discussed include alfalfa, chicory, ginger, fenugreek, garlic, and honey.
Bio pharmaceutical classification System [BCS]Sagar Savale
The Biopharmaceutical Classification System was first developed by in 1995, by Amidon et al & his colleagues.
Definition:
“The Biopharmaceutical Classification System is a scientific framework for classifying a drug substance based on its aqueous solubility & intestinal permeability & dissolution rate”.
To saved time fast screening is required so drug substances are classified on basis of solubility and permeability. This classification is called Biopharmaceutical Classification System
Liquid oral topic in Industrial Pharmacy contains many topics like solution, elixirs, syrups, emulsion, and suspension. This topic includes general introduction, types, formulation, components, uses, and Quality control tests. These are also beneficial in other subjects like Pharmaceutics.
This document provides an overview of the Drugs and Cosmetics Act of 1940 and its rules of 1945 in India. It discusses the history and objectives of the act, key definitions, schedules, provisions around importing and manufacturing drugs, licensing requirements, and offenses and penalties. The act was implemented to regulate the drug industry and ensure safety, quality and standards through licensing and inspection. It covers allopathic, ayurvedic, siddha and unani medicines.
Introduction & Objectives
Schedules of the Act.
Schedules of the Rule
Definitions
Administrative bodies
Import & Registration.
Manufacture of drugs
Sale of drugs
Labeling & packaging of drugs
Conditions for grant of licenses
Detailed study of schedules g, h, M, N, P, T, U,V, X & Y
The Drugs and Cosmetics Act, 1940 is an Act of the Parliament of India which regulates the import, manufacture and distribution of drugs in India. The primary objective of the act is to ensure that the drugs and cosmetics sold in India are safe, effective and conform to state quality standards.
The Drug & Cosmetic Act was passed in 1940 with the objective of regulating the import, manufacture, distribution, and sale of drugs and cosmetics in India. The Act aims to prevent the import and manufacture of substandard or spurious drugs. It provides for control over the sale and distribution of drugs by trained persons and regulates Ayurvedic, Siddha, Unani, and Homeopathic drugs. The Act also regulates import, manufacture, sale and distribution of cosmetics. It provides for regular inspection of licensed premises and control over drug and cosmetic standards.
The Drug and Cosmetic Act of 1940 and Rules of 1945 regulate the import, manufacture, distribution and sale of drugs and cosmetics in India. The objectives are to prevent the import or manufacture of substandard drugs and cosmetics, and ensure they are only distributed by trained professionals. The Act defines key terms like "drug", "cosmetic", and categories of drugs like Ayurvedic and Homeopathic. It establishes standards for quality, prohibits misbranding and adulteration, and defines spurious drugs. Schedules list authoritative texts for Ayurvedic/Siddha/Unani medicines, quality standards, and classify drugs as prescription-only or over-the-counter. The Act aims to
The document provides an overview of the Drugs and Cosmetics Act of 1940 in India. Some key points:
1) The Act was established to regulate the manufacture, sale, and import of drugs and cosmetics in order to ensure quality and safety. It covers definitions, licensing, inspections, and penalties for violations.
2) Administration involves advisory boards, analytical testing labs, and licensing authorities at central and state levels. The Drugs Technical Advisory Board advises the government on technical issues.
3) Manufacturing, sale, and import of drugs require licenses that mandate compliance with good practices, record keeping, and product standards. Violations can result in imprisonment and fines.
The Drug and Cosmetics Act regulates the import, manufacture, distribution and sale of drugs and cosmetics in India. It aims to ensure that imported, manufactured and sold drugs are safe, effective and meet quality standards. Key points covered in the document include:
- Definitions of terms like 'drug', 'cosmetic', 'misbranded', 'adulterated', 'spurious'
- Objectives and chapters of the Act
- Roles of drug inspectors and government analysts
- Standards and schedules referenced in the Act
- Recommendations to expand over-the-counter drug categories
The Drug and Cosmetic Act of 1940 and its Rules of 1945 were passed to regulate the import, manufacture, distribution and sale of drugs and cosmetics in India. The Act defines drugs and cosmetics and establishes schedules that list regulated substances. It provides for licensing of sales and imports, sets labeling and packaging requirements, and qualifies government analysts and drug inspectors to enforce the Act.
The document summarizes key aspects of the Drug and Cosmetic Act and Rules in India, including:
- The Acts and Rules regulate the import, manufacture, distribution and sale of drugs and cosmetics in India.
- Important definitions are provided for terms like "drug", "cosmetic", "manufacture" and others.
- Drugs and cosmetics can be deemed "misbranded", "adulterated" or "spurious" if they do not meet certain standards.
- The Rules contain 18 parts and 26 schedules providing detailed requirements and guidelines for drugs and cosmetics.
- Key agencies like the Drugs Technical Advisory Board help administer the Acts and
The document outlines the key aspects of the Drugs and Cosmetics Act of 1940 and Rules of 1945 in India. It describes the objectives of regulating import, manufacture, sale and distribution of drugs and cosmetics. It then covers the various schedules that list standards and categories of drugs/cosmetics. It also defines terms like misbranded, adulterated and spurious drugs/cosmetics. Finally, it discusses provisions around government analysts, inspectors, their roles and qualifications for enforcing the act.
The Drugs & Cosmetics Act of 1940 established rules for licensing authorities, drug inspectors, and controlling authorities to regulate the import and sale of drugs and cosmetics in India. Key provisions include requirements for licensing authorities and inspectors to have qualifications in pharmacy or medicine. Inspectors are responsible for inspecting licensed establishments, ensuring license conditions are followed, investigating complaints, and maintaining records. The import of certain drug classes like misbranded, substandard, or spurious drugs is prohibited. Conditions for licensing the import of biological, narcotic, and Schedule X drugs as well as drugs for examination, personal use, and manufacturing are outlined. Cosmetics containing harmful ingredients or exceeding limits for heavy metals are also prohibited
The document discusses regulations around the manufacture and sale of cosmetics in India according to the Drugs and Cosmetics Act of 1940. It outlines several prohibited categories of cosmetics including those that are misbranded, adulterated, below standard quality, or contain unsafe ingredients. It also describes the different types of licenses required for manufacturing, wholesale, and retail sale of drugs and cosmetics and the conditions that license holders must satisfy. Record keeping requirements are also specified. Certain drugs and cosmetics are prohibited from import or wholesale based on quality, labeling, or disease treatment claims.
This presentation contains basics of Drugs & Cosmetics Act. All the legal definitions, objective and various schedules belonging to the act are mentioned. This is the first part of Drugs & Cosmetics Act, other parts of the acts will be described in the next presentations.
Drug & Cosmetic ACT 1940 & Rules 1945 unit I.pptxGayatriBahatkar1
Objectives, Definitions, Legal definitions of schedules to the Act and
Rules
Import of drugs – Classes of drugs and cosmetics prohibited from import, Import under
license or permit. Offences and penalties.
Manufacture of drugs – Prohibition of manufacture and sale of certain drugs,
Conditions for grant of license and conditions of license for manufacture of drugs,
Manufacture of drugs for test, examination and analysis, manufacture of new drug, loan
license and repacking license.
DRUG AND COSMETIC ACT -
For more information regarding PHARMACOVIGILANCE, CLINICAL RESEARCH, CLINICAL DATA MANAGEMENT & DRUG REGULATORY AFFAIRS kindly contact us on 9028839789
The document summarizes the Drugs and Cosmetics Act of 1940 and Rules of 1945 in India. Some key points:
- It was enacted to regulate the import, manufacture, distribution and sale of drugs and cosmetics through a licensing system. Only qualified persons can manufacture, distribute and sell drugs and cosmetics.
- It covers definitions of drugs and cosmetics. Provisions relate to import, manufacture, sale, labeling and packaging of drugs. It describes schedules to the act and amendments made over time.
- The act is administered through various advisory committees and authorities like the Drugs Technical Advisory Board and Drugs Control Laboratories. It outlines licensing, manufacturing and sale requirements for different drug categories
This document discusses the import of drugs and cosmetics into India. It begins by defining import, drug, and cosmetic. It then discusses that imported drugs and cosmetics must meet quality standards and cannot be misbranded, adulterated, or spurious. Misbranded drugs do not have proper labels, adulterated drugs contain decomposed substances or were prepared in unsanitary conditions, and spurious drugs are fake versions of other drugs. Certain drugs and cosmetics are prohibited from import if they do not meet these standards or are not properly labelled and packaged. Some drugs can be imported under license, including those in Schedules C, C1, and X or small quantities for testing or personal use
The document summarizes key aspects of the Drug and Cosmetics Act of 1940 and Rules of 1945 in India. It outlines the 18 parts of the Drug and Cosmetics Rules covering different subjects, and the 2 schedules to the act and 26 schedules to the Rules. It provides details on important schedules related to licensing, fees, exempted drugs, Good Manufacturing Practices and requirements. It also describes provisions regarding the manufacture, import, sales, labeling and packaging of drugs and cosmetics.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
1. SHALOM INSTTITUTE OF HEALTH AND ALLIED SCIENCES, FHS, SHUATS
ALLAHABAD
IMPORT OF DRUGS AND COSMETICS
Prepared By:
Name ID No.
Abhishek Kumar Karn 16BPH085
Md. Zaiem Ali 16BPH048
B.Pharmacy
6th semester
Submitted To:
Dr. Vikas Kumar
SIHAS, FHS, SHUATS
3. Definitions
Drugs :
a) substances used for the internal or external indented to be used for or in diagnosis, treatment
,mitigation or prevention of any disease or disorder in human beings or animals including preparation
applied for repelling mosquitoes
b) substances indented to affect any function of human body or indented to be used for the destruction of
vermin or insects that cause disease in human beings or animals
c) all substances indented for use as components of drug including empty gelatin capsules
d) Devices indented for internal or external use in the diagnosis, treatment, mitigation or prevention of
disease or disorder in human beings or animals.
Cosmetic :
Any article intended to be rubbed, poured, sprinkled or sprayed on, or otherwise applied to, the human body
or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, and
includes any article intended for use as a component of cosmetic.
Misbranded drugs :
a) if it is not labelled in the prescribed manner; or
b) if its label or container or anything accompanying the drug bears any statement, design or device which
makes any false claim for the drug or which is false or misleading in any particular.
4. (a) if it consists, in whole or in part, of any filthy, putrid or decomposed substance; or
Adulterated drug :
(b) if it has been prepared, packed or stored under insanitary conditions whereby it may have been contaminated
with filth or whereby it may have been rendered injurious to health; or
(c) if its container is composed in whole or in part, of any poisonous or deleterious substance which may render the
contents injurious to health.
(d) If any substance has been mixed there with so as to reduce its quality or strength.
Spurious Drugs: A drug is deemed to be spurious –
(a) if it is imported under a name which belongs to another drug; or
(b) if it is an imitation/copy of, or a substitute for, another drug or resembles another drug in a manner likely to
deceive or bears upon it or upon its label or container the name of another drug . or
(c) if it has been substituted wholly or in part by another drug or substance.or
Misbranded Cosmetics: A cosmetic is deemed to be misbranded –
(a)If it contains color which is not prescribe; or
(b) If it is not labeled in prescribed manner; or
(c)If the label or container of anything accompanying the cosmetic bears any statement which is false or
misleading in particular.
5. Spurious Cosmetics: A cosmetic is deemed to be spurious –
(a)If it is imported under a name which belongs to another cosmetic; or
(b)If it is an imitation of, or a substitute for, or resembles another cosmetic in a manner likely to deceive or bears
upon it or upon its label or container the name of another cosmetic, unless it is plainly and conspicuously marked so
as to reveal its true character and its lack of identity with such other cosmetic; or
(c)If the label of the container bears the name of an individual or company purporting to be the manufacturer of
the cosmetic, which individual or company is fictitious and does not exist; or
(d)If it purports to be the product of a manufacturer of whom it is not truly a product.
New Drug
(a)A new substance of chemical, biological or biotechnological in origin, in bulk or prepared dosage form used for
prevention, diagnosis, or treatment of disease in man or animal; which except during clinical trials has not been uses
in the country to any significant extent and which has not been recognized in the country as effective and safe for
the proposed claims. or
(b)The drug which is first time introduced in country but previously it is used in other countries.
Import of Drug & Cosmetic
• Some drugs/cosmetics can be imported without any permit, providing they are of standard quality & statement that
they comply with the provisions relating to import has been given to the Customs Collector by manufacturer or
importer.
• Drugs/cosmetics may be imported to India under the authority of a license excepting those whose import is
Prohibited.
● Bring into a country from abroad for sale.
6. Prohibition of Import of certain drugs or cosmetics
• No person can import
1. Any drug/cosmetic which is not of standard quality
2. Any misbranded, spurious or adulterated drug
3. Any misbranded or spurious cosmetic
4. Any drug/cosmetic for import for which license is prescribed otherwise than under & in accordance with such
license.
5. Any patent or proprietary medicine unless there is displayed in the prescribed manner on the label the true
formulae or list of active ingredients in it.
6. Any drugs which purports to claim or mitigate any such disease or ailment specified in schedule j in the rules
7. Any cosmetic which contains an ingredient which may render it unsafe for use.
8. Drugs whose manufacture sale & distribution are prohibited in the country of origin,
9. Drugs not labeled & packed in prescribed manner
10. Biologicals & other special products after the date of their expiry as mentioned in label or those not complying
with the standards of strength, quality, purity as may be specified.
11. Any new drug expect with express permission of licensing authority.
12. Any drug/cosmetic, the import which is prohibited under the rules.
7. Import of Drugs under License
• The following classes of drugs can be imported under the license
1. Drugs specified in Schedule C C1
2. Drugs specified in Schedule X
3. Small quantities of drugs imported for the purpose of examination, test or analysis.
4. Drugs for personal use covered by the prescription of registered medical practitioner.
5. Any new drug
• An application for import license must be made to the proper authority in prescribed form & license remains
valid up to 31st December of the year following the year it was granted unless it was suspended earlier.
• Aggrieved party has the right to appeal in High Court against an order of the drugs controller of India
canceling the import license granted to him.
• A separate license is necessary in respect of drugs from each manufacturer
• A separate license is necessary in respect to drug manufactured in each premises when a single manufacturer
abroad has more than one factory.
• A single application may be made & single license may be issued in respect of import of more than one drug or
class of drugs manufactured by same manufacturer.
8. Import of Schedule C, C1 & X drugs
Licensee must have adequate facility for the storage.
Licensee must maintain a record of the sale, showing the particulars of the names of drugs and of the persons
to whom they have been sold.
Licensee must allow an inspector to inspect premises and to check the records.
Licensee on request shall supply sample of drug from all batches to licensing authority for test or analysis.
Licensee must not sell drugs from which sample is withdrawn.
Import of the Schedule-X drugs (Narcotic & Psychotropic drugs)
Licensee must have adequate storage facility.
Applicant must be reputable in the occupation, trade or business.
licensing authority may refuse to grant the license if the license granted to the applicant previously was
suspended or cancelled.
If the applicant is not satisfied with the decision may appeal to central gov within 30 days.
Drugs Imported for examination, test or analysis
License is necessary under form-11
Must use imported drugs only for said purpose and at the place specified in the license.
Must keep the record with respect to quantities, name of the manufacturer and date of import.
Must allow an inspector to inspect the premises and check the records.
Licensee must keep record of samples imported under the license together with their quantities, date of
importation &name of manufacturer.
9. Import of Drugs for Personal Use:
Up to 100 average doses may be imported without any permit, provided it is part of passenger’s luggage.
More than 100 doses imported with license. Apply on form no.-12-A,12-B
Drugs must be for personal use.
Drugs must be declared to the custom collectors if so directed.
Import of New Drugs:
No new drug can be imported except with the permission of the licensing authority. While applying for such
permission, all documentary & other evidence relating to standards of quality, purity & strength should be supplied to
the licensing authority
• Procedure for Import of New Drugs:
• The drugs should be labeled in conformity with the prescribed rules. All consignments of drugs to be imported
should be accompanied by an invoice or other statement showing the make & address of the manufacturer & the
names & quantities of the drugs. Before importing such drugs, declaration signed by the manufacturer on behalf of the
importer that the drugs comply with the provisions of the Acts & Rules ‘d be supplied to the customs collector.
• Customs Collector can take samples of any drugs in the consignment & forward to the director of laboratory
appointed for this purpose by the Central Government. If report of analysis indicate that the drug in a consignment is
not of standard quality the Customs Collector may direct the imported to export back the consignment to the
manufacturer within two months or forfeit the same to Central Government for destruction.
10. Import of drugs by Govt. Hospitals/Medical Institutions for the treatment of patients:
Small quantities of new drugs otherwise prohibited for import may be imported for the treatment of patients
suffering from life-threatening diseases or diseases causing serious or permanent disability by a medical
officer of Govt. Hospital or Medical Institution. Application for such import must be made in Form 12AA.
Exempted Drugs: the drugs specified in Schedule D are exempted from provisions of import of drugs as follows
Substances not used for medicinal purpose
Drugs in Sch-C1 required for manufacturing and not for medicinal use.
Substances which are both drugs and foods such as: Condensed/Powdered Milk ,Malt, Lactose ,Cereal, Oats
Predigested foods
Ginger, Pepper, Cumin, Cinnamon
Cosmetics prohibited to import
Misbranded cosmetics
Spurious cosmetics
Cosmetic containing harmful ingredients
Cosmetics not of standard quality
which contains more than-2 ppm Arsenic, 20 ppm lead, 100 ppm heavy metals
11. • Ferozpur cantonment & Amritsar
Railway station
• Ranaghat, Bongaon & Mohiassan
Railway Stations
• Raxaul
• Chennai, Kolkata, Mumbai, Cochin &
Kandla
• Chennai, Kolkata, Mumbai, Delhi,
Ahmedabad & Hyderabad
• In respect to drugs imported by rail across the
frontier with Pakistan
• In respect to drugs imported by rail across the frontier with
Bangladesh
• In respect to drugs imported by road & rail connecting India &
Nepal
• In respect to drugs imported by sea into India
• In respect to drugs imported by air into India
Places through which drugs may be imported in India
12. Penalties related to Import
Import of spurious OR
adulterated drug OR drug which
involves risk to human beings or
animals OR drug not having
therapeutic values
Contravention of the provision
OFFENCES PENALTIES
a) 3 years imprisonment and 5000 Rs. fine on first
conviction
b) 5 years imprisonment OR 10000 Rs. fine
OR both for subsequent conviction
a) 6 months imprisonment OR
500 Rs. fine OR both for first conviction
b) 1 year imprisonment OR 1000
Rs. fine for subsequent offence